Mar 07, 2022
103:100
For every 100 shares held, investors received 103. The price per share adjusted from $19100.00 to $18543.69.
The split itself did not change the total investment value.
Daewon Pharmaceutical Co., Ltd (KRX:003220) operates in the Pharmaceuticals: major industry.
Daewon Pharmaceutical Co., Ltd company overviewDaewon Pharmaceutical Co., Ltd's most recent stock split was on March 7, 2022. It was a 103-for-100 forward split, so shareholders received 103 shares for every 100 they held.
Daewon Pharmaceutical Co., Ltd (KRX:003220) has split its stock 14 times: a 21-for-20 split on December 29, 2003, a 5-for-2 split on April 30, 2004, a 2-for-1 split on January 7, 2008, a 11-for-10 split on December 28, 2011, a 11-for-10 split on January 31, 2013, a 21-for-20 split on January 28, 2014, a 21-for-20 split on March 2, 2015, a 103-for-100 split on February 18, 2016, a 103-for-100 split on February 7, 2017, a 21-for-20 split on February 19, 2018, a 103-for-100 split on February 11, 2019, a 103-for-100 split on February 17, 2020, a 21-for-20 split on February 18, 2021, and a 103-for-100 split on March 7, 2022.
Daewon Pharmaceutical Co., Ltd has split its stock 14 times. This history records 14 forward splits between December 29, 2003 and March 7, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Daewon Pharmaceutical Co., Ltd's 103-for-100 split on March 7, 2022, every 100 shares became 103 shares.
Daewon Pharmaceutical Co., Ltd has not announced a new split in our records. Its most recent split was on March 7, 2022, 4 years ago. Companies announce splits in advance, and any new KRX:003220 split will appear on this page.
Already premium?